The nation of Zimbabwe has rejected a substantial US health deal valued at $367m (272 million pounds) over five years over the United States' request for confidential data.
The decision became public following a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official representative later clarified that the US was demanding access to genetic material for scientific study and commercial gain while was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further talks to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Implications
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and accountability.
Based on reports, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"In essence, our nation would supply the raw materials for scientific discovery without any assurance that the end products would be accessible to our population if a new health crisis arise."
National Interest and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining structures previously set up via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further dialogue with our US partners on how future co-operation might be designed in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
Medical experts stated it acknowledged the official position, but recommended that talks need to persist since a large portion of the nation's HIV programmes were funded by external financing.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it added.
This impasse highlights the complex challenges between accepting much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.